| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 3.075 | 6.856 | 10.596 | 13.055 | 17.505 | 22.830 |
| Total Income - EUR | - | - | - | - | 3.075 | 6.856 | 10.596 | 13.055 | 17.505 | 22.830 |
| Total Expenses - EUR | - | - | - | - | 35 | 90 | 49 | 3.771 | 2.059 | 6.118 |
| Gross Profit/Loss - EUR | - | - | - | - | 3.040 | 6.766 | 10.547 | 9.284 | 15.446 | 16.711 |
| Net Profit/Loss - EUR | - | - | - | - | 2.947 | 6.561 | 10.258 | 8.968 | 12.975 | 13.975 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Stănculete Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 3.023 | 8.484 | 14.865 | 9.310 | 13.804 | 49.542 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 141 | 1.170 | 8.136 | 41.111 |
| Cash | - | - | - | - | 3.023 | 8.484 | 14.724 | 8.140 | 5.668 | 8.432 |
| Shareholders Funds | - | - | - | - | 2.990 | 8.405 | 14.621 | 9.008 | 13.016 | 14.016 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 33 | 79 | 245 | 302 | 788 | 35.527 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Stănculete Med S.r.l.